Inclusion bodies are a site of ebolavirus replication
Inclusion bodies are a characteristic feature of ebolavirus infections in cells. They contain large numbers of preformed nucleocapsids, but their biological significance has been debated, and they have been suggested to be aggregates of viral proteins without any further biological function. However...
Uloženo v:
| Vydáno v: | Journal of virology Ročník 86; číslo 21; s. 11779 |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.11.2012
|
| Témata: | |
| ISSN: | 1098-5514, 1098-5514 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Inclusion bodies are a characteristic feature of ebolavirus infections in cells. They contain large numbers of preformed nucleocapsids, but their biological significance has been debated, and they have been suggested to be aggregates of viral proteins without any further biological function. However, recent data for other viruses that produce similar structures have suggested that inclusion bodies might be involved in genome replication and transcription. In order to study filovirus inclusion bodies, we fused mCherry to the ebolavirus polymerase L, which is found in inclusion bodies. The resulting L-mCherry fusion protein was functional in minigenome assays and incorporated into virus-like particles. Importantly, L-mCherry fluorescence in transfected cells was readily detectable and distributed in a punctate pattern characteristic for inclusion bodies. A recombinant ebolavirus encoding L-mCherry instead of L was rescued and showed virtually identical growth kinetics and endpoint titers to those for wild-type virus. Using this virus, we showed that the onset of inclusion body formation corresponds to the onset of viral genome replication, but that viral transcription occurs prior to inclusion body formation. Live-cell imaging further showed that inclusion bodies are highly dynamic structures and that they can undergo dramatic reorganization during cell division. Finally, by labeling nascent RNAs using click technology we showed that inclusion bodies are indeed the site of viral RNA synthesis. Based on these data we conclude that, rather than being inert aggregates of nucleocapsids, ebolavirus inclusion bodies are in fact complex and dynamic structures and an important site at which viral RNA replication takes place. |
|---|---|
| AbstractList | Inclusion bodies are a characteristic feature of ebolavirus infections in cells. They contain large numbers of preformed nucleocapsids, but their biological significance has been debated, and they have been suggested to be aggregates of viral proteins without any further biological function. However, recent data for other viruses that produce similar structures have suggested that inclusion bodies might be involved in genome replication and transcription. In order to study filovirus inclusion bodies, we fused mCherry to the ebolavirus polymerase L, which is found in inclusion bodies. The resulting L-mCherry fusion protein was functional in minigenome assays and incorporated into virus-like particles. Importantly, L-mCherry fluorescence in transfected cells was readily detectable and distributed in a punctate pattern characteristic for inclusion bodies. A recombinant ebolavirus encoding L-mCherry instead of L was rescued and showed virtually identical growth kinetics and endpoint titers to those for wild-type virus. Using this virus, we showed that the onset of inclusion body formation corresponds to the onset of viral genome replication, but that viral transcription occurs prior to inclusion body formation. Live-cell imaging further showed that inclusion bodies are highly dynamic structures and that they can undergo dramatic reorganization during cell division. Finally, by labeling nascent RNAs using click technology we showed that inclusion bodies are indeed the site of viral RNA synthesis. Based on these data we conclude that, rather than being inert aggregates of nucleocapsids, ebolavirus inclusion bodies are in fact complex and dynamic structures and an important site at which viral RNA replication takes place. Inclusion bodies are a characteristic feature of ebolavirus infections in cells. They contain large numbers of preformed nucleocapsids, but their biological significance has been debated, and they have been suggested to be aggregates of viral proteins without any further biological function. However, recent data for other viruses that produce similar structures have suggested that inclusion bodies might be involved in genome replication and transcription. In order to study filovirus inclusion bodies, we fused mCherry to the ebolavirus polymerase L, which is found in inclusion bodies. The resulting L-mCherry fusion protein was functional in minigenome assays and incorporated into virus-like particles. Importantly, L-mCherry fluorescence in transfected cells was readily detectable and distributed in a punctate pattern characteristic for inclusion bodies. A recombinant ebolavirus encoding L-mCherry instead of L was rescued and showed virtually identical growth kinetics and endpoint titers to those for wild-type virus. Using this virus, we showed that the onset of inclusion body formation corresponds to the onset of viral genome replication, but that viral transcription occurs prior to inclusion body formation. Live-cell imaging further showed that inclusion bodies are highly dynamic structures and that they can undergo dramatic reorganization during cell division. Finally, by labeling nascent RNAs using click technology we showed that inclusion bodies are indeed the site of viral RNA synthesis. Based on these data we conclude that, rather than being inert aggregates of nucleocapsids, ebolavirus inclusion bodies are in fact complex and dynamic structures and an important site at which viral RNA replication takes place.Inclusion bodies are a characteristic feature of ebolavirus infections in cells. They contain large numbers of preformed nucleocapsids, but their biological significance has been debated, and they have been suggested to be aggregates of viral proteins without any further biological function. However, recent data for other viruses that produce similar structures have suggested that inclusion bodies might be involved in genome replication and transcription. In order to study filovirus inclusion bodies, we fused mCherry to the ebolavirus polymerase L, which is found in inclusion bodies. The resulting L-mCherry fusion protein was functional in minigenome assays and incorporated into virus-like particles. Importantly, L-mCherry fluorescence in transfected cells was readily detectable and distributed in a punctate pattern characteristic for inclusion bodies. A recombinant ebolavirus encoding L-mCherry instead of L was rescued and showed virtually identical growth kinetics and endpoint titers to those for wild-type virus. Using this virus, we showed that the onset of inclusion body formation corresponds to the onset of viral genome replication, but that viral transcription occurs prior to inclusion body formation. Live-cell imaging further showed that inclusion bodies are highly dynamic structures and that they can undergo dramatic reorganization during cell division. Finally, by labeling nascent RNAs using click technology we showed that inclusion bodies are indeed the site of viral RNA synthesis. Based on these data we conclude that, rather than being inert aggregates of nucleocapsids, ebolavirus inclusion bodies are in fact complex and dynamic structures and an important site at which viral RNA replication takes place. |
| Author | Feldmann, Heinz Groseth, Allison Schudt, Gordian Herwig, Astrid Weber, Michaela Dolnik, Olga Basler, Christopher F Shabman, Reed S Hoenen, Thomas Becker, Stephan |
| Author_xml | – sequence: 1 givenname: Thomas surname: Hoenen fullname: Hoenen, Thomas organization: Laboratory for Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, USA – sequence: 2 givenname: Reed S surname: Shabman fullname: Shabman, Reed S – sequence: 3 givenname: Allison surname: Groseth fullname: Groseth, Allison – sequence: 4 givenname: Astrid surname: Herwig fullname: Herwig, Astrid – sequence: 5 givenname: Michaela surname: Weber fullname: Weber, Michaela – sequence: 6 givenname: Gordian surname: Schudt fullname: Schudt, Gordian – sequence: 7 givenname: Olga surname: Dolnik fullname: Dolnik, Olga – sequence: 8 givenname: Christopher F surname: Basler fullname: Basler, Christopher F – sequence: 9 givenname: Stephan surname: Becker fullname: Becker, Stephan – sequence: 10 givenname: Heinz surname: Feldmann fullname: Feldmann, Heinz |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22915810$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj01LxDAURYOMOB-6cy1ZuumYl-Z10qUMjlYG3KjbkqavEGmbmrSC_96CI7i698LhwlmzRe97YuwaxBZA6rvn92IrACUmIM_YCkSuE0RQi399ydYxfggBSmXqgi2lzAE1iBXDorftFJ3veeVrR5GbQNzw6EbivuFU-dZ8uTBFHmhonTXjzF6y88a0ka5OuWFvh4fX_VNyfHks9vfHxKLQY6KtkRWhFoSmbhqTkUSNSFJAqkHWmNkmB5lqRTq32a6Zl7apIbXLQUAmN-z293cI_nOiOJadi5ba1vTkp1jOgqgQdZbO6M0JnaqO6nIIrjPhu_xTlT_7gVVU |
| CitedBy_id | crossref_primary_10_1038_s41467_021_21630_5 crossref_primary_10_1073_pnas_1307681110 crossref_primary_10_1107_S2059798318007878 crossref_primary_10_1146_annurev_genom_083115_022446 crossref_primary_10_1016_j_jmb_2023_168153 crossref_primary_10_1371_journal_ppat_1007733 crossref_primary_10_1016_j_cellin_2023_100103 crossref_primary_10_1128_jvi_00900_22 crossref_primary_10_1016_j_bbamcr_2020_118831 crossref_primary_10_1016_j_jmb_2025_169366 crossref_primary_10_1038_s42003_024_06130_8 crossref_primary_10_1016_j_virol_2017_09_006 crossref_primary_10_3390_v11010025 crossref_primary_10_1371_journal_ppat_1004463 crossref_primary_10_1128_JVI_00459_16 crossref_primary_10_1128_JVI_01014_19 crossref_primary_10_1371_journal_ppat_1010616 crossref_primary_10_3390_cells14130947 crossref_primary_10_1128_jvi_01020_24 crossref_primary_10_1091_mbc_E19_09_0490 crossref_primary_10_1016_j_cell_2024_11_024 crossref_primary_10_3390_biom11091324 crossref_primary_10_1128_jvi_01083_22 crossref_primary_10_1016_j_micinf_2024_105402 crossref_primary_10_1056_NEJMra1901594 crossref_primary_10_3390_cells9051126 crossref_primary_10_1038_s42003_024_06300_8 crossref_primary_10_1016_j_ab_2020_113691 crossref_primary_10_1242_jcs_262164 crossref_primary_10_3390_v11040372 crossref_primary_10_1016_j_str_2023_06_004 crossref_primary_10_1371_journal_ppat_1005937 crossref_primary_10_3390_cells10061460 crossref_primary_10_1038_s41467_020_16768_7 crossref_primary_10_1128_JVI_00179_17 crossref_primary_10_3390_molecules24030481 crossref_primary_10_1038_s41467_022_29948_4 crossref_primary_10_1128_JVI_01068_20 crossref_primary_10_3390_v4101878 crossref_primary_10_1093_infdis_jiw270 crossref_primary_10_1128_JVI_01819_15 crossref_primary_10_1007_s13238_020_00764_0 crossref_primary_10_1021_jacs_3c06965 crossref_primary_10_1038_s41564_024_01703_z crossref_primary_10_1080_22221751_2019_1659552 crossref_primary_10_1128_JVI_01372_19 crossref_primary_10_1016_j_antiviral_2018_12_006 crossref_primary_10_1186_s12985_019_1267_9 crossref_primary_10_1146_annurev_virology_093020_013659 crossref_primary_10_3390_pathogens10101330 crossref_primary_10_1371_journal_ppat_1003358 crossref_primary_10_3389_fimmu_2017_01197 crossref_primary_10_3390_v14071523 crossref_primary_10_1128_jvi_01319_22 crossref_primary_10_1038_s41467_025_57236_4 crossref_primary_10_1038_nrd_2017_251 crossref_primary_10_3390_microorganisms8101535 crossref_primary_10_1038_s41564_025_02034_3 crossref_primary_10_3390_ijms23105491 crossref_primary_10_1016_j_antiviral_2014_01_003 crossref_primary_10_1016_j_jmb_2023_168241 crossref_primary_10_1016_j_virol_2015_06_013 crossref_primary_10_3390_ijms25031638 crossref_primary_10_1038_srep34589 crossref_primary_10_1093_infdis_jiv111 crossref_primary_10_1007_s12250_019_00122_3 crossref_primary_10_1016_j_antiviral_2019_104569 crossref_primary_10_1128_JVI_01726_17 crossref_primary_10_1128_JVI_02267_14 crossref_primary_10_1371_journal_pbio_3002871 crossref_primary_10_1099_jgv_0_002021 crossref_primary_10_3390_v10010028 crossref_primary_10_1128_JVI_03544_12 crossref_primary_10_1016_j_coviro_2020_05_006 crossref_primary_10_3390_ijms24108471 crossref_primary_10_1016_j_virol_2018_02_008 crossref_primary_10_1128_JVI_00177_17 crossref_primary_10_1128_JVI_03343_14 crossref_primary_10_1093_infdis_jiv083 crossref_primary_10_1016_j_antiviral_2020_104907 crossref_primary_10_1128_JVI_03257_15 crossref_primary_10_1038_s41467_017_00655_9 crossref_primary_10_1099_jgv_0_000564 crossref_primary_10_1371_journal_ppat_1008987 crossref_primary_10_3390_v12101179 crossref_primary_10_1080_22221751_2023_2223727 crossref_primary_10_1016_j_tibs_2022_09_008 crossref_primary_10_1038_s41467_024_51356_z crossref_primary_10_1038_s41579_019_0233_2 crossref_primary_10_1093_infdis_jiz440 crossref_primary_10_1093_infdis_jiv240 crossref_primary_10_1186_s13073_018_0570_1 crossref_primary_10_3390_cells9071728 crossref_primary_10_3390_ijms21239045 crossref_primary_10_1099_jgv_0_001261 crossref_primary_10_1007_s00705_013_1877_2 crossref_primary_10_1371_journal_pntd_0005996 crossref_primary_10_1016_j_jmb_2019_06_029 crossref_primary_10_1038_s41467_023_39821_7 crossref_primary_10_3390_ijms23158122 crossref_primary_10_3390_v13010126 crossref_primary_10_1371_journal_ppat_1010530 crossref_primary_10_7554_eLife_74884 crossref_primary_10_1186_s12985_025_02784_w crossref_primary_10_1080_22221751_2023_2223732 crossref_primary_10_1002_pro_2541 crossref_primary_10_1080_13543784_2021_1881061 crossref_primary_10_1093_infdis_jiu681 crossref_primary_10_1586_14787210_2014_948848 crossref_primary_10_1128_JVI_02100_19 crossref_primary_10_7554_eLife_88122 crossref_primary_10_1128_spectrum_02373_23 crossref_primary_10_1128_JVI_02170_19 crossref_primary_10_3390_v11050410 crossref_primary_10_3390_v13020201 crossref_primary_10_3390_cells9010187 crossref_primary_10_1016_j_ejcb_2015_05_006 crossref_primary_10_1016_j_omto_2023_05_006 crossref_primary_10_1080_07391102_2020_1756409 crossref_primary_10_1007_s40475_015_0039_x crossref_primary_10_1128_JVI_00948_19 crossref_primary_10_1128_JVI_01802_16 crossref_primary_10_3390_v14071563 crossref_primary_10_3390_ijms24076550 crossref_primary_10_1128_JVI_01863_14 crossref_primary_10_3390_ijms26178485 crossref_primary_10_1038_s41467_017_00102_9 crossref_primary_10_7554_eLife_88122_3 crossref_primary_10_1016_j_virusres_2019_03_002 crossref_primary_10_1016_j_ymthe_2022_10_011 crossref_primary_10_1128_JVI_01272_14 crossref_primary_10_3390_v14051044 crossref_primary_10_3390_v15020554 crossref_primary_10_1093_infdis_jiy424 crossref_primary_10_3390_ijms25052993 crossref_primary_10_1080_22221751_2019_1662736 crossref_primary_10_1016_j_cell_2024_08_044 crossref_primary_10_1093_jmicro_dfac049 crossref_primary_10_3390_v15010122 crossref_primary_10_1371_journal_ppat_1003147 crossref_primary_10_1016_j_antiviral_2013_05_017 crossref_primary_10_1074_jbc_RA120_015661 crossref_primary_10_1073_pnas_1712263115 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/JVI.01525-12 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1098-5514 |
| ExternalDocumentID | 22915810 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: AI093786 – fundername: NIAID NIH HHS grantid: R56 AI093786 – fundername: NIAID NIH HHS grantid: R01 AI059536 – fundername: NIAID NIH HHS grantid: AI059536 |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A NPM O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM 7X8 |
| ID | FETCH-LOGICAL-c508t-8ca2be580e5adffa6e25855e2013812d56cf912384e89c67ff918c3ae47910162 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 172 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000309657100035&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1098-5514 |
| IngestDate | Wed Oct 01 15:10:58 EDT 2025 Mon Jul 21 05:43:30 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 21 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c508t-8ca2be580e5adffa6e25855e2013812d56cf912384e89c67ff918c3ae47910162 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://jvi.asm.org/content/jvi/86/21/11779.full.pdf |
| PMID | 22915810 |
| PQID | 1095455863 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1095455863 pubmed_primary_22915810 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-11-01 |
| PublicationDateYYYYMMDD | 2012-11-01 |
| PublicationDate_xml | – month: 11 year: 2012 text: 2012-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of virology |
| PublicationTitleAlternate | J Virol |
| PublicationYear | 2012 |
| SSID | ssj0014464 |
| Score | 2.4967513 |
| Snippet | Inclusion bodies are a characteristic feature of ebolavirus infections in cells. They contain large numbers of preformed nucleocapsids, but their biological... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 11779 |
| SubjectTerms | Animals Artificial Gene Fusion Cell Line Ebolavirus - physiology Genes, Reporter Humans Inclusion Bodies, Viral - virology Luminescent Proteins - analysis Luminescent Proteins - genetics Microscopy, Fluorescence Recombinant Fusion Proteins - analysis Recombinant Fusion Proteins - genetics Red Fluorescent Protein RNA-Dependent RNA Polymerase - genetics Transfection Viral Proteins - genetics Virus Replication |
| Title | Inclusion bodies are a site of ebolavirus replication |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22915810 https://www.proquest.com/docview/1095455863 |
| Volume | 86 |
| WOSCitedRecordID | wos000309657100035&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFH-oU_Di93R-EcFrtM3aND2JiENFxw46ditJmsBgtLPdBv73vrSdOwmCl0IPfYTXl_f1e8kP4NqLNPMkV9RikUyDVCgqfD-mqRVe6kdSy4rubfga9ftiNIoHTcOtbMYqlz6xctRprl2PHHd3jME-FLx7N_2kjjXKoasNhcY6tLqYyjirjkYrFAFLnQpVdndmusxgOfjOxO3L8PnGc9w_1HFR_pZcVkGmt_vf5e3BTpNekvvaHvZhzWQHsFUTTn4dQojuYDJ3DTKicjc_SGRhiCROCsktQeczkYtxMS9JYX6Q7SP46D2-PzzRhjiBasy3ZlSghpUJhWdCmVoruWFYFYSGOVjSZ2nItY0xZInAiFjzyOKb0F1pgih21Txrw0aWZ-YEiMcVR1FWGm0DzZXC9CBVEcqwWNgxvwNXS30kaJgObZCZyedlstJIB45rpSbT-gaNhLHYD4Xvnf7h6zPYxnWz-vzfObQsbktzAZt6MRuXxWX1x_HZH7x9A2VUtLA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inclusion+bodies+are+a+site+of+ebolavirus+replication&rft.jtitle=Journal+of+virology&rft.au=Hoenen%2C+Thomas&rft.au=Shabman%2C+Reed+S&rft.au=Groseth%2C+Allison&rft.au=Herwig%2C+Astrid&rft.date=2012-11-01&rft.issn=1098-5514&rft.eissn=1098-5514&rft.volume=86&rft.issue=21&rft.spage=11779&rft_id=info:doi/10.1128%2FJVI.01525-12&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-5514&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-5514&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-5514&client=summon |